PRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation. Oxford, UK – 30 March 2022:…

Continue ReadingPRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

Optellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report

Optellum is referenced within the report with recommendations on how AI will be implemented and physicians trained in new technologies across the NHS Optellum has been named as one of…

Continue ReadingOptellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report

AI software could help clinicians diagnose lung cancer earlier and reduce waiting lists for patients

A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding. This is a…

Continue ReadingAI software could help clinicians diagnose lung cancer earlier and reduce waiting lists for patients

US PRESS RELEASE: Optellum Receives FDA Clearance for the World’s First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis

Virtual Nodule Clinic empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is now commercially available in the United States. Oxford, United Kingdom – March 23,…

Continue ReadingUS PRESS RELEASE: Optellum Receives FDA Clearance for the World’s First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis